A detailed history of Colony Group LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Colony Group LLC holds 1,672 shares of SRPT stock, worth $211,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,672
Holding current value
$211,992
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $171,380 - $206,642
1,672 New
1,672 $203,000
Q1 2023

May 16, 2023

BUY
$117.53 - $155.99 $940 - $1,247
8 Added 0.48%
1,674 $231,000
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $168,032 - $220,128
1,666 New
1,666 $216,000
Q1 2021

May 21, 2021

SELL
$72.25 - $168.95 $121,091 - $283,160
-1,676 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $5,022 - $7,149
-40 Reduced 2.33%
1,676 $286,000
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $159,588 - $294,637
1,716 New
1,716 $275,000
Q1 2020

May 18, 2020

SELL
$82.38 - $131.64 $141,364 - $225,894
-1,716 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$76.53 - $135.58 $131,325 - $232,655
1,716 New
1,716 $221,000
Q3 2019

Nov 26, 2019

SELL
$72.81 - $156.91 $124,941 - $269,257
-1,716 Closed
0 $0
Q2 2019

Aug 19, 2019

SELL
$112.21 - $151.95 $3,366 - $4,558
-30 Reduced 1.72%
1,716 $261,000
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $186,245 - $264,833
1,746 New
1,746 $208,000
Q4 2018

Feb 15, 2019

SELL
$97.32 - $148.76 $169,920 - $259,734
-1,746 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$71.74 - $153.69 $125,258 - $268,342
1,746 New
1,746 $231,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.1B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.